Related to Sinovac Wins $1.8M Chinese Flu Vaccine Contract and Gets Anflu Sanctioned in Hong Kong

• Neurotez Scores $2.73M to Progress Preclinical Leptin Therapy for Alzheimer’s Disease
  
• Grant to Pluristem Increased by $0.4M to Advance Cell Therapy for Critical Limb Ischemia
  
• ImmunoVaccine Technologies Collaborates with Scancell to Advance DNA Vaccine Delivery
  
• Evotec Buys 70% of Indian Drug Discovery Services Firm for Over $4M
  
• Inovio and NIH Vaccines Research Center Ally on Swine Flu and Universal DNA Vaccines
  
• Biota and Daiichi Sankyo’s Flu Therapy Shows Positive Phase III Results
  
• Thermo Fisher Scientific Sets Up RNAi Discovery Grant Program
  
• City of Hope to Research Advaxis’ Leukemia and Lymphoma Vaccine
  
• GSK Wins Accelerated Approval of Hib Vaccine to Help Sustain Supply
  
• $1.3 Flemish Government Grant to Support Clinical Trials of ActoGeniX’ Oral Mucositis Therapy
  
• French Government Awards TcL Roughly $3.15M for Research on CD28 Antagonists in Transplant Therapy
  
• U.K. Government Gives Regenerative Medicine a £1.5M Boost
  
• BrainStorm Cell Therapeutics Taps Israeli CMO for Stem Cell Production
  
• Ono Gains Rights to Tioga’s IBS Therapy in Japan, South Korea, and Taiwan
  
• International Institute of Biomedical Sciences and Technology Has Been Formed by Institutes in NY, Israel, and Taiwan
  
• Synexus Expands Operations in South Africa with Two Clinical Trial Research Units
  
• NIH Grants $2.87M for Development of Treatment for C. difficile and Shigella Gastrointestinal Infections
  
• FDA Lifts Hold on Dynavax’ Phase III HBV Vaccine
  
• German Federal Grant Funds Biomarker Research to Speed Up Protein Kinase Inhibitor Development
  
• Nacalai Gains Distribution Rights to  LifeSensors’ Products in Asian Market